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Malignant ventricular arrhythmias, including ventricular
tachycardia and ventricular ﬁbrillation (VF), are leading
causes of total and cardiovascular mortality (1,2). Sudden
cardiac death resulting from these ventricular arrhythmias
represents a signiﬁcant unsolved clinical problem (1,2).
Sudden cardiac death after ventricular arrhythmia in adults is
most frequently caused by the sequelae of myocardial
ischemia or myocardial infarction (MI) (1). Epidemiological
studies have indicated that sudden death of a family member
is a risk factor for sudden cardiac death (2). Two groups have
compared individuals with and without VF during the early
phase of a ﬁrst MI and found that family history of sudden
death is a strong risk factor for cardiac arrest during
myocardial ischemia or MI (3,4). These reports suggest that
common genetic factors underlie susceptibility to VF during
myocardial ischemia or MI.See page 549Genome-wide association studies are a high-throughput
genotyping method to search for associations between a
large number of single-nucleotide polymorphisms (SNPs)
and phenotypic traits (5). Bezzina et al. (6) used this method
to investigate patients with acute MI, focusing on a highly
speciﬁc arrhythmic phenotype to minimize heterogeneity.*Editorials published in the Journal of the American College of Cardiology reﬂect the
views of the authors and do not necessarily represent the views of JACC or the
American College of Cardiology.
From the yDivision of Cardiovascular Medicine, Department of Internal Medicine,
Kurume University School of Medicine, Kurume, Japan; and the zCardiovascular
Research Institute, Kurume University School of Medicine, Kurume, Japan. The
authors have reported that they have no relationships relevant to the contents of this
paper to disclose.Their results show a signiﬁcant association between the SNP
rs2824292 on chromosome 21q21 and VF in patients with
acute MI. Perhaps their most compelling ﬁnding is that the
susceptibility allele is located near the CXADR gene, which
encodes the coxsackievirus and adenovirus receptor (CAR)
protein.
CAR is a 46-kDa type I transmembrane protein of the
tight junction and intercalated discs that functions in
maintaining cell–cell contacts through its extracellular
Immunoglobulin (Ig) domains (7,8). CAR was initially
identiﬁed as a common receptor involved in virus uptake and
has been implicated in viral myocarditis and dilated car-
diomyopathy in mice and humans (7,8). Recent reports
indicate that CAR expression is required for normal em-
bryonic development and that its myocardium-speciﬁc
disruption interrupts electrical conduction between the
atria and ventricles, leading to complete heart block and loss
of connexin 45 (Cx45) in the atrioventricular (AV) node
(9,10). These ﬁndings indicate that CAR expression is
required for normal function of AV conduction; however,
the role of CAR in ventricular conduction and the causal
relationship between CAR and ventricular arrhythmogeneity
and susceptibility remain unknown.
In this issue of the Journal, Marsman et al. (11) report that
CAR is a novel modiﬁer of ventricular conduction and
arrhythmia vulnerability in the setting of myocardial
ischemia. Their examination of human left ventricular tis-
sues reveals that the risk allele at rs2824292, which was
previously linked to VF during MI, is associated with
decreased expression of the CAR-encoding CXADR gene,
suggesting that reduced cardiac levels of CAR predispose to
VF during myocardial ischemia. CAR-haploinsufﬁcient
mice (CARþ/) exhibit slowing of ventricular conduction
and an earlier onset of inducible ventricular tachycardia
during myocardial ischemia. Patch-clamp analysis of isolated
CARþ/ cardiomyocytes showed reduced sodium channel
availability, secondary to a reduced sodium current density
speciﬁcally at the intercalated disc. In vitro binding analysis
revealed interaction between CAR protein and the sodium
channel Nav1.5. Thus, expression studies using human MI
samples combined with studies in CARþ/ mice clearly
indicate a novel role of CAR in ventricular conduction and
arrhythmogenesis during perturbed conditions, such as
myocardial ischemia.
Various CAR-deﬁcient animal models have been gener-
ated to gain additional insight into its physiological func-
tions (9–15). Global CAR knockout mice exhibit embryonic
lethality due to cardiac defects, indicating the essential role
of CAR for normal cardiac development (12,13). Studies
using cardiac-speciﬁc CAR knockout mice have revealed
that CAR plays an essential role in normal AV conduction,
associated with loss of Cx45 localization at the AV node
cell–cell junction (9,10). Additionally, Lim et al. (10) re-
ported that cardiac-speciﬁc CAR knockout mice exhibit
disorganization of the intercalated disc ultrastructure and
late-onset dilated cardiomyopathy. These murine studies
Figure 1
Proposed Scheme for the Induction of Ventricular
Arrhythmia in CAR-Haploinsufﬁcient Mice During
Acute Myocardial Infarction
CAR physiologically interacts with the major cardiac sodium channel Nav1.5 and
reduces the sodium current density speciﬁcally at the intercalated disc. In addition
to CAR haploinsufﬁciency, perturbed stimuli such as ischemia may be required for
the generation of ventricular arrhythmia. CAR ¼ coxsackievirus and adenovirus
receptor; MI ¼ myocardial infarction.
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561clearly indicate that CAR plays essential physiological roles
in normal cardiac development, AV node conduction, and
cardiac function. By contrast, the CARþ/ mice used by
Marsman et al. (11) were normally born at the expected
Mendelian ratio, exhibited no ultrastructural changes, and
had a normal life span. The expression levels and localiza-
tions of intercalated disc proteins, including Cx43, were
comparable between CARþ/ mice and wild-type mice, and
the CARþ/ mice did not exhibit spontaneous ventricular
arrhythmias at baseline (11). Because cardiac structure and
function were normal in CARþ/ mice without ischemic
insult, these mice are suitable for investigating whether the
risk haplotype tagged by rs2824292 is a susceptibility locus
for ventricular arrhythmia during myocardial ischemia.
One key ﬁnding of Marsman et al. (11) is that ventric-
ular tachycardia was induced in CARþ/ mice during acute
ischemia or infusion of the gap junctional uncoupler car-
benoxolone. It is known that carbenoxolone causes cellular
electrical uncoupling and slowing of conduction in ven-
tricular myocardium, without affecting action potential
characteristics or the underlying major ion currents (16). It
is conceivable that, in addition to CAR haploinsufﬁciency,
perturbed stimuli such as ischemia or carbenoxolone may be
required for the generation of ventricular arrhythmia.
Another important ﬁnding is that CAR physiologically
interacts with the major cardiac sodium channel Nav1.5,
reducing sodium current density speciﬁcally at the inter-
calated disc (11). Nav1.5 is a major cardiac voltage-gated
sodium channel a-subunit, and mutations in the Nav1.5-
encoding SCN5A gene are associated with a variety of
arrhythmic disorders, including long QT, Brugada, and sick
sinus syndromes, as well as primary cardiac conductiondiseases and idiopathic VF (17,18). Recent studies
demonstrated that in vivo interaction between structural
proteins and Nav1.5 at the intercalated disc provides a
molecular pathway for electrical disturbances (19,20).
Therefore, the increased susceptibility to ventricular arr-
hythmia in CARþ/ mice may result from the interplay
between structural (i.e., CAR) and electrical (i.e., Nav1.5)
proteins at the intercalated disc under perturbed conditions,
such as acute ischemia (Fig 1).
CAR is a multifunctional molecule for cell–cell interac-
tion, virus uptake, cardiac development and function, AV
node conduction, and ventricular arrhythmogenesis. Various
therapeutic applications have been proposed, including the
use of CAR-transgenic erythrocytes or soluble CAR to
eliminate CVB3 infection (21,22). In fact, virally induced
myocarditis and cardiac dysfunction are substantially pre-
vented in cardiac-speciﬁc CAR-deﬁcient mice (14,15).
However, when inhibiting CAR expression, one must be
aware of the potential unexpected effects, such as heart block
and ventricular arrhythmia.
Several interesting questions remain unanswered: How
are cardiac function and mortality in CARþ/ mice after MI
in vivo? Does CAR haploinsufﬁciency affect cardiac elec-
trical activity during other pathophysiological conditions,
including post-infarct heart failure or pressure overload–
induced cardiac hypertrophy and failure? How does CAR
interact with and modulate the Nav1.5 protein at the mo-
lecular level? Is there an association between risk haplotype
tagged by rs2824292 and sudden cardiac death by VF in
other cardiovascular diseases, such as cardiomyopathy and
myocarditis?
In summary, the studies of Marsman et al. (11) in human
cardiac samples combined with their electrophysiological
studies in CARþ/ mice establish a novel role for CAR in
mediating ventricular conduction and arrhythmogenesis
during perturbed conditions, such as gap junctional uncou-
pling and myocardial ischemia. Their ﬁndings suggest that
CAR may be a susceptibility factor for life-threatening
ventricular arrhythmia during acute myocardial ischemia.
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